Oslo, Norway

Ingelin Clausen

This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Sintef Tto as. Active years: 2022.


% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.7

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ingelin Clausen: Innovator in In-Vivo Monitoring Technologies

Introduction

Ingelin Clausen is a prominent inventor based in Oslo, Norway. She has made significant contributions to the field of in-vivo monitoring technologies, particularly through her innovative sensor assemblies. With a total of 2 patents, Clausen's work is paving the way for advancements in medical monitoring systems.

Latest Patents

Clausen's latest patents include a sensor assembly designed for in-vivo monitoring of body fluids or tissues. This sensor assembly features a pressure sensor element that utilizes a micro-electromechanical system (MEMS) to detect pressure accurately. The design includes a protective shield that surrounds the pressure sensor element, ensuring its integrity and preventing distortion during use. Additionally, the pressure sensor element is coated with a biocompatible thin film layer to resist corrosion and fouling from biological matter. Another notable patent is her in-vivo pressure monitoring system, which comprises a delivery component and an elongate sensor delivery member. This system is designed to facilitate the monitoring of pressure in body fluids, enhancing patient care.

Career Highlights

Ingelin Clausen has established herself as a key figure in her field, working at Sintef Tto AS. Her innovative approach and dedication to research have led to the development of cutting-edge technologies that improve medical monitoring capabilities.

Collaborations

Clausen collaborates with notable colleagues, including Thomas Glott and Lars Geir Whist Tvedt. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ingelin Clausen's contributions to in-vivo monitoring technologies exemplify her commitment to advancing medical science. Her patents reflect a deep understanding of the challenges in the field and a drive to create effective solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…